Healthcare provider profile · identity verified

Itamar Levari

Internal Medicine · MONROEVILLE, PA · NPI 1891953840

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	296	81
Amlodipine Besylate	Amlodipine Besylate	294	83
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	211	40
Gabapentin	Gabapentin	188	43
Lisinopril	Lisinopril	167	49
Pantoprazole Sodium	Pantoprazole Sodium	161	49
Alprazolam	Alprazolam	159	30
Tramadol Hcl	Tramadol Hcl	153	32
Losartan Potassium	Losartan Potassium	151	42
Albuterol Sulfate Hfa	Albuterol Sulfate	136	32
Levothyroxine Sodium	Levothyroxine Sodium	133	35
Eliquis	Apixaban	131	26
Metoprolol Succinate	Metoprolol Succinate	122	33
Hydrochlorothiazide	Hydrochlorothiazide	118	32
Metformin Hcl	Metformin Hcl	117	30
Metoprolol Tartrate	Metoprolol Tartrate	114	35
Potassium Chloride	Potassium Chloride	109	35
Omeprazole	Omeprazole	108	30
Oxycodone Hcl	Oxycodone Hcl	106	26
Simvastatin	Simvastatin	100	30
Tamsulosin Hcl	Tamsulosin Hcl	98	28
Furosemide	Furosemide	91	36
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	81	11
Acetaminophen-Codeine	Acetaminophen With Codeine	71	suppressed
Ozempic	Semaglutide	71	suppressed
Allopurinol	Allopurinol	70	18
Jardiance	Empagliflozin	70	17
Escitalopram Oxalate	Escitalopram Oxalate	67	23
Glimepiride	Glimepiride	67	19
Atenolol	Atenolol	66	19
Clopidogrel	Clopidogrel Bisulfate	65	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	18
Prednisone	Prednisone	63	35
Carvedilol	Carvedilol	54	15
Lorazepam	Lorazepam	54	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	15
Quetiapine Fumarate	Quetiapine Fumarate	48	suppressed
Spironolactone	Spironolactone	48	16
Rosuvastatin Calcium	Rosuvastatin Calcium	47	14
Famotidine	Famotidine	44	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	11
Clonazepam	Clonazepam	43	11
Trazodone Hcl	Trazodone Hcl	43	16
Temazepam	Temazepam	42	suppressed
Montelukast Sodium	Montelukast Sodium	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	11
Sertraline Hcl	Sertraline Hcl	39	11
Metformin Hcl Er	Metformin Hcl	37	suppressed
Ventolin Hfa	Albuterol Sulfate	37	12
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	11
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Tradjenta	Linagliptin	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	11
Warfarin Sodium	Warfarin Sodium	30	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	28	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	suppressed
Digoxin	Digoxin	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Baclofen	Baclofen	25	suppressed
Lidocaine	Lidocaine	25	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Azithromycin	Azithromycin	24	21
Buspirone Hcl	Buspirone Hcl	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Nitroglycerin	Nitroglycerin	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	18
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Methotrexate	Methotrexate Sodium	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Dutasteride	Dutasteride	17	suppressed
Jantoven	Warfarin Sodium	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Nystatin	Nystatin	17	suppressed
Clonidine	Clonidine	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Fentanyl	Fentanyl	15	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Sulfasalazine	Sulfasalazine	15	suppressed
Glipizide	Glipizide	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	12
Celecoxib	Celecoxib	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Finasteride	Finasteride	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Naproxen	Naproxen	13	suppressed
Tiotropium Bromide	Tiotropium Bromide	13	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxymorphone Hcl Er	Oxymorphone Hcl	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Topiramate	Topiramate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error